Document is current
Any future updates will be listed below
-
Authors
Jiang, Xiao
Xiu, Yufang
Jia, Chang
Han, Bo
Zu, Jianyu
Zhang, Shanni
Han, Nana
Pan, Lingling
Sun, Huixuan
Li, Jing
Wang, Yingjian
Wang, Kean
Man, Yufei
Liu, Wenchao
Guan, Zhenzhou
Yao, Fang
Jin, Ning
Xue, Zhiqiang
Yuan, Wenhua
Li, Peng
Gong, Yuyue
Wang, Qi
Lu, Sijin
Wang, Huijun
Sun, Yingjie
Diao, Yugang
Cao, Huijuan https://orcid.org/0009-0004-8280-1326
-
Funding
Funding for this research was provided by:
Shenyang Municipal Bureau of Science and Technology (23-408-3-03)
- License Information
-
More Information
Article History
Received: 17 October 2025
Accepted: 16 December 2025
First Online: 29 January 2026
Declarations
:
: Xiao Jiang, Yufang Xiu, Chang Jia, Bo Han, Jianyu Zu, Shanni Zhang, Nanna Han, Lingling Pan, Huixuan Sun, Jing Li, Yingjian Wang, Kean Wang, Yufei Man, Wenchao Liu, Zhenzhou Guan, Fang Yao, Ning Jin, Zhiqiang Xue, Wenhua Yuan, Peng Li, Yuyue Gong, Qi Wang, Sijin Lu, Huijun Wang, Yingjie Sun, Yugang Diao, and Huijuan Cao have nothing to disclose.
: The study protocol was approved by the Ethics Committee of the General Hospital of the Northern Theater Command of the Chinese People’s Liberation Army (Approval No. Y [2023] 069). All participating sites accepted the central approval. The clinical trial registration number was ChiCTR2300072104, and the period of the study was from June 2023 to June 2024. The study protocol was conducted in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Written informed consent was obtained from all participants prior to enrollment.
